Prenetics Global Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 275.76 million compared to USD 275.85 million a year ago. Net loss was USD 190.45 million compared to USD 174.01 million a year ago.

Basic loss per share from continuing operations was USD 37.5 compared to USD 178.7999 a year ago. Diluted loss per share from continuing operations was USD 37.5 compared to USD 178.7999 a year ago.